다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Rani Therapeutics Holdings Inc (RANI)
Rani Therapeutics Holdings Inc (RANI) 뉴스

RANI

Rani Therapeutics (RANI)

Rani Therapeutics Holdings Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:RANI

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/03/27	05:05	GlobeNewswire Inc.	Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill® Capsule, to Subcutaneously Administered PG-102	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2025/03/26	07:00	GlobeNewswire Inc.	Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2025/02/06	06:05	GlobeNewswire Inc.	Rani Therapeutics Announces Preclinical Data Demonstrating Successful Oral Delivery of Semaglutide via RaniPill® HC	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/12/18	07:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/12/18	07:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/12/17	08:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/12/11	03:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/11/14	22:20	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/11/14	22:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/11/14	22:00	GlobeNewswire Inc.	Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/11/08	06:05	GlobeNewswire Inc.	Rani Therapeutics to Participate in Upcoming Investor Conferences	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/10/17	21:00	GlobeNewswire Inc.	Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/10/16	19:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/10/16	19:04	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/10/15	21:30	GlobeNewswire Inc.	Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/10/09	05:05	GlobeNewswire Inc.	Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/09/12	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/09/04	05:05	GlobeNewswire Inc.	Rani Therapeutics to Participate in September Investor Conferences	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/08/07	05:09	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/08/07	05:05	GlobeNewswire Inc.	Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/08/07	05:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/07/30	05:05	GlobeNewswire Inc.	Rani Therapeutics to Participate in August Investor Conferences	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/07/23	19:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/07/23	19:05	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/07/22	21:30	GlobeNewswire Inc.	Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/07/13	06:19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/06/24	20:00	GlobeNewswire Inc.	Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/05/31	05:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/05/14	21:00	GlobeNewswire Inc.	Rani Therapeutics to Participate in May Investor Conferences	NASDAQ:RANI	Rani Therapeutics Holdings Inc
2024/05/09	21:00	GlobeNewswire Inc.	Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024	NASDAQ:RANI	Rani Therapeutics Holdings Inc

검색 관련기사 보기:NASDAQ:RANI

1 2 3 4 5 6 7 다음 >>

Am Gv Bond G Hd

VanEck Robotics ETF

Gblqtyincusdinc

DJ Islamic Market AsiaPa...

First Trust Global Funds... (GM)

iShares China Index ETF

NioCorp Developments

Western Forest Products

First Trust Nasdaq Lux D...

Payoneer Global

Vontobel Financial Produ...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관